載入...
Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
Metastatic urothelial carcinoma of the bladder is an aggressive malignancy with poor prognosis, reflecting a lack of effective systemic therapies. The current standard of care includes multiagent platinum-based chemotherapy; however a majority of patients do not respond to treatment and most eventua...
Na minha lista:
| 發表在: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352238/ https://ncbi.nlm.nih.gov/pubmed/28331342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S109453 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|